The molecular mechanisms controlling mouse embryonic stem cell (ESC) metastability, i.e. their capacity to fluctuate between different states of pluripotency, are not fully resolved. We developed and used a novel automation platform, the Cell maker , to screen a library of metabolites on two ESC-based phenotypic assays (i.e. proliferation and colony phenotype) and identified two metabolically related amino acids, namely L-proline (L-Pro) and L-ornithine (L-Orn), as key regulators of ESC metastability. Both compounds, but mainly L-Pro, force ESCs toward a novel epiblast stem cell (EpiSC)-like state, in a dose-and time-dependent manner. Unlike EpiSCs, L-Pro-induced cells (PiCs) contribute to chimeric embryos and rely on leukemia inhibitor factor (LIF) to self-renew. Furthermore, PiCs revert to ESCs or differentiate randomly upon removal of either L-Pro or LIF, respectively. Remarkably, PiC generation depends on both L-Pro metabolism (uptake and oxidation) and Fgf5 induction, and is strongly counteracted by antioxidants, mainly L-ascorbic acid (vitamin C, Vc). ESCs ↔ PiCs phenotypic transition thus represents a previously undefined dynamic equilibrium between pluripotent states, which can be unbalanced either toward an EpiSC-like or an ESC phenotype by L-Pro/L-Orn or Vc treatments, respectively. All together, our data provide evidence that ESC metastability can be regulated at a metabolic level.
Introduction
Two types of pluripotent stem cells have been isolated from mouse embryos: embryonic stem cells (ESCs), derived from the blastocysts of pre-implantation embryos (Evans and Kaufman, 1981; Martin, 1981) , and epiblast stem cells (EpiSCs), originating from late epiblast or primitive ectoderm (PrE) of early postimplantation embryos (Brons et al., 2007; Tesar et al., 2007) . Although sharing an unlimited self-renewal capacity, ESCs and EpiSCs differ by gene expression profile, growth factors/signaling reliance, and colony morphology. Although the SON triade of transcription factors (Sox2, Oct4, and Nanog) (Mitsui et al., 2003; Masui et al., 2007; Niwa, 2007) is highly expressed in both cell types, ESCs display a Rex1 + /Fgf5 2 phenotype, while
EpiSCs exhibit a Rex1 2 /Fgf5 + phenotype. Rex1 (Zfp42) encodes a transcription factor highly expressed in the inner cell mass (ICM) but down regulated in the PrE (Rogers et al., 1991; Pelton et al., 2002) , whereas Fgf5 (fibroblast growth factor 5 gene), almost absent in ICM, is highly induced in PrE (Haub and Goldfarb, 1991) . In addition, ESCs depend on leukemia inhibitory factor (LIF) and bone morphogenetic protein 4 (BMP4) (Ying et al., 2003) to proliferate remaining undifferentiated, whereas EpiSCs rely on basic FGF (bFGF) and Activin/TGFb signaling (Brons et al., 2007; Tesar et al., 2007) . Furthermore, while ESCs grow developing three-dimensional rounded colonies with regular borders, EpiSCs proliferate forming bi-dimensional flat-shaped colonies with irregular borders. Recently, a near-pluripotent stem cell type, namely FGF, Activin, and BIO-derived stem cells (FAB -SCs), was isolated from the ICM of blastocysts (Chou et al., 2008) . Similarly to EpiSCs, however, FAB-SCs rely on bFGF/Activin and develop flat-shaped monolayer colonies. It has been recently reported that cultured ESCs consist of a heterogeneous cell population fluctuating between different states of pluripotency. At the extremes of this phenotypic variation cells display identifiable features of ESCs or EpiSCs, respectively (Hayashi et al., 2008; Toyooka et al., 2008; Kalmar et al., 2009) . Moreover, early primitive ectoderm-like cells (EPLCs) displaying a Rex1 2 /Fgf5 + , flat-shaped phenotype, and bFGF/ Activin reliance were generated incubating ESCs in HepG2 (hepatocellular carcinoma) cell line-conditioned medium (Rathjen et al., 1999) , and EpiSC-like cells developed culturing ESCs in a medium containing high levels of bFGF/Activin without fetal bovine serum (FBS) and LIF (Guo et al., 2009) . On the other hand, a stringent ESC medium (LIF plus FBS) was sufficient to revert both EPLCs and EpiSCs to an ESC-like state (Rathjen et al., 1999; Hanna et al., 2009) . Based on these data, it clearly emerges that: (i) the ESC EpiSC-like phenotypic transition is reversible and regulated by growth factors; (ii) cells relying on LIF/STAT3 and BMP4 signaling grow stacked (multilayered), whereas cells depending on bFGF and Activin/TGFb signaling proliferate as a monolayer.
Recently, considerable efforts have been focused on the development of new tools and methodologies to identify extrinsic factors/small molecules able to modulate the pluripotent state of ESCs. Here, we used an innovative robotic platform, the Cell maker , designed to automate the screening of compound collections on ESC proliferation, colony morphology, or differentiation and identified, through the screening of a library of metabolites, key regulators of ESC proliferation and ESC EpiSC transition.
Results
The Cell maker : a fully automated platform combining HTS with ESC-based assays We have designed the Cell maker to perform high-throughput molecular screenings on ESC-based phenotypic assays (proliferation/ differentiation). The robotic system ( Figure 1A ) was assembled integrating robot-accessible instruments (incubators, multi-signal reader) with a liquid-handling workstation through three different transfer units (a robotic arm, a linear transfer trail and a grip) (Supplemental Figure S1 ). The Cell maker is guided by a software allowing a dynamic scheduling of operations ranging from a single task, such as 'cell plating', to multi-task processes as 'colony phenotype' assay. Furthermore, lab-set up protocols improved the Cell maker performance by providing a quantifiable readout for each phenotype analyzed. In its current configuration, the Cell maker can handle, in complete automation, up to 4000 mini-cultures (96-well format) of ESCs. Notably, we established that the Cell maker executes both ESC proliferation and colony formation assays with high standards of reliability and accuracy (Supplemental Figure S2 ; data not shown). These results prompted us to exploit the Cell maker technology to search for metabolites acting as ESC regulators.
L-Pro and L-Orn induce ESC proliferation
We used the Cell maker to screen a homemade assembled library of metabolites on the proliferation of TBV2-derived cells expressing enhanced green fluorescence protein (EGFP) under the control of the housekeeping b-actin gene promoter (b-actin/EGFP cells), and identified L-Pro and L-Orn as putative inducers of ESC proliferation ( Figure 1B) . Indeed, mini-cultures of cells supplemented with L-Pro or L-Orn emitted fluorescent signals 2-fold higher than untreated ones ( Figure 1B ). Most remarkably, cells cultured in the presence of L-Pro or L-Orn developed wider colonies compared with untreated controls ( Figure 1C) . Moreover, both amino acids stimulated ESC proliferation in a dose-dependent manner, although with different kinetics ( Figure 1D ): at concentrations ranging from 30 mM to 1 mM, L-Pro showed a higher efficacy than L-Orn, inducing the greatest proliferation response already at 100 mM. A 20-fold higher concentration of L-Orn (i.e. 2 mM) was required to achieve a similar pro-proliferative effect. We then used the parental (i.e. non-engineered) TBV2 cells and, in agreement with the Cell maker results, the cell density of cultures treated with L-Pro was 2-fold higher compared with untreated ESCs ( Figure 1E ).
To assess the cell line-specificity of L-Pro effect, we used different unrelated cells. Remarkably, all the ESC lines assayed were susceptible, at a different extent, to L-Pro addition ( Figure 1F) ; conversely, none of the non-ESC lines assayed responded to L-Pro stimulation ( Figure 1F ), suggesting that L-Pro responsiveness is a specific feature of ESCs.
L-Pro and L-Orn force ESCs toward an EpiSC-like phenotype Given the pro-proliferative effect of L-Pro and L-Orn, we asked whether these metabolites might also affect the morphology of ESCs. To this end, we further exploited the Cell maker to assay our library of metabolites on the colony phenotype of wild-type TBV2 cells (Figure 2) . Unexpectedly, the colonies assumed a clearcut EpiSC-like morphology upon treatment with either L-Pro or L-Orn ( Figure 2A) . These results were further validated by means of manual assays ( Figure 2B ). As expected, 90% of the colonies in untreated controls displayed a characteristic roundshaped three-dimensional (domed) morphology, with uniform and birefringent edges. Conversely, 90% of the colonies developed in the presence of L-Pro showed a flat-shaped twodimensional phenotype with irregular edges ( Figure 2B ). Remarkably, densely packed cells of 'typical' domed colonies and epithelial-like cells of 'atypical' flat colonies displayed a similar ultrastructure with a high nuclear -cytoplasmic ratio, a characteristic trait of pluripotent stem cells, prominent nucleoli and rod-shaped mitochondria ( Figure 2C ). Unlike L-Pro, treatment with L-Orn, even at high concentrations, resulted in only 50% of the cell colonies displaying a flat-shaped morphology, indicating that L-Orn induces the phenotypic transition less efficiently than L-Pro ( Figure 2B ). Noteworthy, no difference was observed in the colony-formation efficiency of TBV2 ESCs plated either in the presence or in the absence of L-Pro/L-Orn (≥96%; see "Materials and methods"). Remarkably, even at high L-Pro concentrations, a significant fraction (up to 10%) of the colonies persistently displayed the typical ESC shape, indicating that a subpopulation of ESCs are unresponsive to L-Pro.
L-Pro and L-Orn induce the phenotypic switch in a dose-and time-dependent manner Physiological concentrations of L-Pro in human and mouse plasma range from 0.1 mM to 0.5 mM. We thus used the Cell maker to evaluate the effect of increasing concentrations of both L-Pro and L-Orn on the colony phenotype of TBV2 ESCs. This analysis revealed significant differences in the efficiency of both amino acids to induce the ESC EpiSC-like transition ( Figure 2D ). Indeed, low amounts of L-Pro ( 30 mM) already induced the formation of a significant fraction ( 25%) of atypical (flat or mixed shape) cell colonies compared with control (4%-8%). Differently, a 30-fold higher concentration of L-Orn (i.e. 1 mM) was required to stimulate a similar phenotypic variation ( Figure 2D) . The results were then validated in manual assays and, remarkably, up from 75 mM L-Pro, the majority of the colonies (85%-90%) displayed a clear-cut EpiSC-like morphology, after 4 days in culture ( Figure 2E) . Thus, physiological concentrations of L-Pro were sufficient to trigger the phenotypic switch of ESCs. Moreover, the L-Pro-induced phenotypic transition was achieved seeding ESCs (TBV2 and E14 lines) at a clonal density (from 10 to 50 cells/ cm 2 ) on gelatin-coated feeder-free plates (Supplemental Figure  S3A and D). It is worth nothing that, the phenotypic transition was strongly influenced by the density of feeder cells (Supplemental Figure S3B) . Indeed, a high-density layer of mouse embryo fibroblasts (MEFs), but not their conditioned medium, forced ESCs to developed round-shaped colonies even at high L-Pro concentrations; whereas, on a low-density layer of MEFs, ESCs developed flat-shaped (monolayer) colonies. Interestingly, we noticed that fibroblasts represented a physical barrier for the spreading of colonies (Supplemental Figure S3B ), confirming that, unlike ESCs, L-Pro-induced cells (PiCs) are unable to grow forming multilayered colonies. Worth noting, round-shaped colonies developed in the presence of L-Pro on a high-density layer of MEFs retain pluripotency markers, such as alkaline phosphatase activity (Supplemental Figure S3C) .
In order to determine the time required for L-Pro to induce the EpiSC-like morphology, we performed a L-Pro time course on a colony assay by progressively withdrawing L-Pro from the culture medium ( Figure 2F ). Eighteen hours of L-Pro treatment were sufficient to trigger efficiently the morphological transition ( 90% of flat-shaped colonies) and, thus, the commitment of ESCs toward an EpiSC-like phenotype.
The induction of the EpiSC-like phenotype relies on intracellular L-Pro
L-serine (L-Ser) and L-alanine (L-Ala) compete with L-Pro for different neutral amino acid uptake/transport systems, such as ATA2 (also named SNAT2 or SAT2), in many cell lines ( Figure 3A) . Interestingly, neither L-Ser nor L-Ala was recognized as a hit in our screening. To first confirm the inability of these amino acids to influence ESC colony phenotype, we performed a manual colony assay using L-Pro in the presence of 15-fold excess of L-Ser and L-Ala, provided either alone or in combination ( Figure 2G ). Remarkably, the simultaneous addition of both competitors to the culture medium inhibited, almost completely, L-Pro but not L-Orn activity ( Figure 2G ), thus suggesting that L-Pro internalization was required to induce the phenotypic transition. Worth noting, several ESC lines are cultured in medium supplemented with a mixture of non-essential amino acids (NEAA) containing, among others, L-Pro, L-Ser and L-Ala (100 mM each). We thus performed colony assays in the presence of NEAA, seeding TBV2 cells at a clonal density (25 cells/cm 2 ), and found that 50% of the colonies displayed a flat morphology (data not shown). Interestingly, this fraction was significantly higher compared with the absence of NEAA (i.e. 8%-10%), but much lower compared with L-Pro treatment (85%-90%, 100 mM L-Pro). Thus, we concluded that the presence of NEAA in the culture medium may influence ESC colony phenotype.
L-Orn could either be catabolized to polyamines or converted to D 1 -pyrroline-5-carboxylate (P5C) and, eventually, to L-Pro ( Figure 3A) . It is thus tempting to reason that L-Orn L-Pro conversion might account for the L-Orn activity. Therefore, in an attempt to increase the intracellular levels of P5C or L-Pro from L-Orn, we treated the cells with a-difluoromethylornithine (DFMO), a potent suicide inhibitor of the first enzyme of polyamines biosynthesis, i.e. ornithine decarboxylase (ODC). Interestingly, ESCs mainly developed typical round-shaped colonies when treated with a sub-optimal concentration of L-Orn (0.5 mM) ( Figure 2H ), whereas, they primarily gave rise to atypical flat-shaped colonies, if simultaneously treated with a sub-lethal concentration (2 mM) of DFMO ( Figure 2H ). Interestingly, DFMO per se forced ESCs toward a flat-shaped phenotype ( Figure 2H ), although cell proliferation was severely impaired, thus excluding a role of polyamines in the induction of the morphological transition. Conversely, our data suggest that L-Pro itself or P5C, the metabolic intermediate in L-Orn L-Pro conversion ( Figure 3A ), may be the triggering factor for the EpiSC-like phenotype induction. Thus, EpiSC-like (flat-shaped) cells generated by both amino acids, L-Pro and L-Orn, were named PiCs. POX activity is required for L-Pro-but not L-Orn-induced PiC phenotype Once transported within cells, L-Pro can be either anabolized (protein synthesis) or eventually catabolized, i.e. oxidized for energy production ( Figure 3A) . Proline oxidase (POX), a mitochondrial inner membrane enzyme, catalyzes the first rate-limiting step of L-Pro degradation, i.e. its conversion to P5C ( Figure 3A) . Hence, we evaluated the effect of a competitive inhibitor of POX, the 3,4-dehydro-L-proline (DHP) on L-Pro (in 50 mM) activity in colony phenotype assay (CPA) at day 5 ( Figure 4A and B) . Interestingly, a 3-fold excess of DHP (150 mM) inhibited PiC formation almost completely ( Figure 4A) . Conversely, DHP was unable to counteract the L-Orn ability to induce PiCs ( Figure 4A ). Since L-Pro P5C conversion is POX-dependent, while L-Orn P5C conversion is POX-independent ( Figure 3A ), our data point to a key role of P5C in the molecular mechanisms underlying ESC morphological transition.
The POX inhibitor was also able to reduce the pro-proliferative effect of both L-Pro ( Figure 4B ) and L-Orn (data not shown), suggesting that the L-Pro cycle ( Figure 3A) is involved in the induction of ESC proliferation. Indeed, L-Pro cycle activation could enhance the recovery of ATP/energy from the NADPH, mainly generated by glucose catabolism through the pentose phosphate (PP) pathway ( Figure 3A) . On the basis of this consideration, we assayed the effect of L-Pro and L-Orn on the proliferation/phenotype of a TBV2-derived ESC line lacking the first enzyme of the PP pathway, i.e. glucose-6-phosphate dehydrogenase (G6PD) (Paglialunga et al., 2004) . Interestingly, G6PD null ESCs responded inefficiently to the pro-proliferative stimulus of both L-Pro and L-Orn and developed much smaller atypical (flat or mixed shape) colonies than the parental TBV2 cells (data not shown), thus suggesting that ESC proliferation, but not ESC PiC transition, depends, at least to some extent, on PP pathway.
Antioxidants, mainly Vc, inhibit L-Pro-and L-Orn-mediated induction of PiCs Reactive oxygen species (ROS) are by-products of POX activity ( Figure 3A ) and might thus be involved in the L-Pro-induced phenotypic transition. To get some insights into this issue, we performed ESC colony assays in the presence of increasing amount of well-known ROS scavengers (antioxidants), namely glutathione (GSH), N-acetyl-L-cysteine (NAC), and L-ascorbic acid (vitamin C, Vc). Both GSH and NAC prevented the formation of PiCs in a dosedependent manner reaching a full counteracting activity at concentrations 7-and 30-fold higher than L-Pro (150 mM), respectively ( Figure 4C and D) . Conversely, Vc affected L-Pro activity already at 50 mM (i.e. 3-fold lower than L-Pro), while at 200 mM it almost completely inhibited PiC formation ( Figure 4E) . Moreover, Vc also blocked the L-Orn-induced transition ( Figure 4E ). Most remarkably, the fraction ( 10%) of atypical (flat-shaped) colonies, consistently developed by TBV2 cells in feeder-free conditions, disappeared in the presence of Vc ( Figure 4E ). On the other hand, neither Vc nor GSH/NAC inhibited the pro-proliferative effect of L-Pro/L-Orn ( Figure 4F and data not shown).
PiCs express markers of pluripotency
To evaluate whether PiCs retained pluripotency properties, we analyzed the expression of pluripotency genes/markers ( Figure 5 ). While comparable levels of Sox2, Oct3/4, Nodal, and Cripto transcripts were detected in ESCs and PiCs, Nanog transcripts were reduced ( 2-fold) in PiCs ( Figure 5A) . Similarly, Gbx2 (gastrulation brain homeobox 2), Rex1 (Zfp42, zinc finger protein 42 homolog), and CRTR-1 (a transcriptional repressor of the CP2 family) were also downregulated ( Figure 5A) . Interestingly, Gbx2, Rex1, and CRTR1 are markers of mouse ICM, and are all downregulated upon PrE formation. On the contrary, Fut4 (fucosyltransferase 4) increased 10-fold in PiCs compared with ESCs. Furthermore, Fgf5, which is upregulated both in late epiblast and EpiSCs, was induced 100-fold in PiCs ( Figure 5A ). We then assessed the expression of SSEA1 (stagespecific embryonic antigen-1), Oct3/4, and E-cadherin (Ca 2+ -dependent adhesion molecule) by immunofluorescence analysis ( Figure 5B) . Remarkably, SSEA1 and Oct3/4 were detected at the plasma membrane (SSEA1) and in the nuclei (Oct3/4) of both ESCs and PiCs. On the contrary, while E-cadherin expression was detected at the membrane of ESCs, it almost completely disappeared in PiCs ( Figure 5B) . Interestingly, like EpiSCs, PiCs displayed low levels of alkaline phosphatase activity (Supplemental Figure S3C) . To gain deeper insights into the molecular analysis, we evaluated the expression of a-N-acetylgalactosamine (GalNAc), a surface marker of ESCs (Nash et al., 2007) . Fluorescence-activated cell sorter (FACS) flow cytometry analysis showed a marked reduction in GalNAc during ESC PiC transition ( Figure 5C ). Hence, all together our data indicate that PiCs display a profile of 'stemness' markers similar to that of epiblast-like cells either derived from mouse embryos or spontaneously formed in standard ESC cultures.
PiCs require L-Pro and mLIF to self-renew To assess the self-renewal ability of PiCs, we subcultured them for several continuous passages on gelatin-coated feeder-free plates in the presence of both LIF and L-Pro ( Figure 5D ). Notably, as described for EpiSCs (Brons et al., 2007) , PiCs are highly susceptible to trypsinization and require milder proteolytic/collagenolytic enzymatic treatments, i.e. accutase, for cell dissociation. After several passages, PiCs retained both their morphology and specific gene expression profiles, i.e. equal levels of Oct3/4 and SSEA1, high Fgf5, low Gbx2, and Rex1 levels ( Figure 5D and F) . Remarkably, we found that PiCs could survive to .30 passages without any appreciable loss of their phenotype (data not shown). Conversely, after five passages in the absence of L-Pro, cells reverted to ESC features as shown by morphological and molecular analysis ( Figure 5E and F) . Worth noting, a CPA performed plating PiCs (passage 7) at a low density and in the absence of L-Pro was sufficient to induce the PiC ESC morphological reversion ( Figure 5G) . Indeed, while only 10% of the colonies displayed an ESC-like morphology in the presence of L-Pro, a more significative fraction, up to 60%, was observed in the absence of L-Pro ( Figure 5G ). Worth noting, the colony formation efficiency of PiCs was unaffected by L-Pro treatment (data not shown). These data indicate that the phenotypic reversion is not due to selective proliferation of ESCs subpopulation persisting in PiC cultures. Concluding, PiCs and ESCs are likely in a dynamic equilibrium and L-Pro thrusts the cells to adopt an EpiSC-like phenotype.
We established that LIF was essential to achieve the phenotypic transition (PiC induction; Figure 6A and B). Indeed, randomly differentiated cells were clearly evident already at day 3 in CPAs with L-Pro but in the absence of LIF ( Figure 6A ). Moreover, 2 days later (i.e. at day 5 from seeding), high levels of Gata4 (meso-endoderm) and Brachyury (a pan mesodermal marker) were measured, while expression of Sox1 and Pax6 was almost undetectable, indicating the presence of differentiated cells ( Figure 6B) . Moreover, random differentiation was also observed after three rounds of subculturing in the presence of L-Pro but in the absence of LIF ( Figure 6B ), thus indicating that LIF was essential for PiCs to self-renew. Interestingly, it has been previously shown that EpiSCs require bFGF and Activin A to self-renew (Brons et al., 2007; Tesar et al., 2007) ; thus, to evaluate whether bFGF and Activin A could replace LIF requirement to support PiC self-renewal, we performed a molecular analysis after three rounds of PiC subculturing in the presence of bFGF (10 ng/ml) and Activin A (50 ng/ml), without LIF. Interestingly, while the pluripotency markers Oct3/4 and Nanog were downregulated, the expression of Gata4 and Brachyury (T) strongly increased ( Figure 6C ), indicating that bFGF and Activin A, induced differentiation rather than supporting PiC self-renewal, thus being unable to replace LIF function ( Figure 6C ). These data indicate that LIF is required for both generation and maintenance of PiCs; furthermore, while LIF removal promotes differentiation during PiC propagation, L-Pro removal induces the reversion of PiCs toward an ESC phenotype.
PiC formation depends on Fgf5 induction
Fgf5 is a late epiblast marker during embryo development and is strongly induced in PiCs ( Figure 5A) . Thus, to assess if Fgf5 exerted a functional role in establishing the PiC phenotype, silencing experiments were performed using short-hairpin RNA (shRNA), which targeted Fgf5 mRNA sequence. Two independent ESC clones were isolated (583 and 586), with a silencing efficacy of 40% and 85% in the presence of L-Pro, respectively ( Figure 7C) ; these clones were used in CPAs in the presence of L-Pro (50 mM-1 mM). Fgf5-silenced ESCs were less responsive to L-Pro compared with control (non-targeting control vector); indeed, the fraction of cells unresponsive to L-Pro stimulus (i.e. maintaining the typical domed ESC phenotype) increased as the level of Fgf5 transcripts decreased ( Figure 7A and B). In line with these results, the expression of ESC-specific markers, such as Rex1 and Gbx2, increased ( Figure 7C) . Moreover, in the presence of L-Pro, Fgf5-silenced ESCs developed smaller flat-shaped colonies compared with control ( Figure 7B) . Remarkably, the L-Pro-unresponsive phenotype was completely reverted, in a dose-dependent manner, upon addition of recombinant FGF5 protein to Fgf5-silenced ESCs ( Figure 7D ). All together these data pointed to a functional role of Fgf5 expression in the L-Pro-induced ESC PiC-like transition.
PiCs are pluripotent stem cells that retain differentiation potential both in vitro and in vivo
We explored the differentiation potential of PiCs both in vitro and in vivo. We first used the embryoid body (EB)-based cardiac differentiation protocol (Maltsev et al., 1993) and showed that PIC-derived EBs were able to generate areas of contracting cardiomyocytes (beating foci, data not shown). Cardiac differentiation was confirmed by immunofluorescence, using a-myosin heavy chain (a-MHC) antibodies ( Figure 8A) , and Q-PCR for gene expression analysis of cardiac mesoderm specific markers such as Nkx2.5 ( Figure 8C) . Notably, expression of Afp (a-fetoprotein) was also strongly induced in PiC-derived EBs ( Figure 8C ), suggesting that PiCs could also differentiate into mesendoderm derivatives. PiCs were also fully capable to differentiate into neurons and glia (Fico et al., 2008) as shown by immunofluorescence using anti b-III tubulin and GFAP (glial fibrillary acidic protein) antibodies, which mark neurons and glia, respectively ( Figure 8B) , and Q-PCR analysis of neural specific markers Pax6 (neuroectoderm) and Nfm (neurons) ( Figure 8C) .
Moreover, we evaluated whether PiCs could give rise to teratomas in vivo. Upon injection into immunocompromised mice, PiCs generated teratomas characterized by the presence of different tissues, such as connective, cartilage, muscle, and epithelial tissues ( Figure 8D ), providing evidence of their pluripotency properties in vivo.
Finally, to further explore the developmental potential of PiCs in vivo, we evaluated their ability to contribute to chimeric embryos. Thus, we injected EGFP-labeled PiCs into blastocysts and found that donor PiCs contributed to development of chimeric embryos ( Figure 8E ) with high frequency (9 out of 10 embryos). Comparable results were obtained using ESCs reverted from PiCs (PiCs rev ) after subculturing in the absence of L-Pro (passage 5; data not shown). Overall, these results indicate that PiCs have full capacity to differentiate into the three embryonic germ layers in vivo.
Discussion
Over the last few years, the identification of new regulators of stem cell proliferation and/or differentiation, which are essential to realize the potential of regenerative medicine, has been greatly facilitated by the application of automation technologies. We successfully used a novel robotic platform, the Cell maker , on phenotype-based screenings (i.e. ESC proliferation/CPAs) and identified two metabolically related amino acids, namely L-Pro and L-Orn, as ESC regulators. Worth noting, a third metabolite was found, namely L-Lysine, which acts as a potent inhibitor of ESC proliferation (our unpublished data). Interestingly, a similar inhibitor effect of L-lysine on HeLa cell proliferation was early reported (Eagle, 1955) . In line with our findings, Washington et al. (2010) and 5 in a colony phenotype assay; L-Pro was added at 2.5 mM with or without mLIF. Scale bars, 50 mm (Upper), 100 mm (Lower). (B) RT-PCR analysis of early-differentiation markers: Gata4 (mesoendodermal), T (Brachyury, mesodermal), Sox1 and Pax6 (neuroectodermal). Gapdh was used as an internal control. Right-side histograms refer the densitometric analysis of amplification results, normalized to Gapdh. (C) PiCs were subcultured for three passages either with LIF or without LIF +/2bFGF/Activin A. Q-PCR analysis of pluripotency markers (Nanog and Oct3/4) and mesodermal markers (Brachyury and Gata4) reported as fold changes in gene expression of PiCs -LIF or PiCs -LIF +bFGF/Activin A versus PiCs +LIF (control). mRNA was normalized to Gapdh, data are means + SD (n ¼ 3).
cells. Since L-Orn shows a 20-fold lower effectiveness than L-Pro, and its activity likely depends on its conversion into L-Pro, cells generated by both these amino acids were named PiCs. PiCs are similar to pluripotent EpiSCs by different criteria, such as colony morphology, susceptibility to trypsinization, gene expression profile, and pluripotency, but differ in growth factors/signaling reliance, since they strictly depend on LIF to proliferate remaining undifferentiated, while EpiSCs rely on FGF/ TGFb signaling (Brons et al., 2007; Tesar et al., 2007) . More interestingly, unlike EpiSCs, PiCs efficiently contribute to chimeric embryos. Notably, PiCs promptly revert to the ESC phenotype after removal of L-Pro, indicating that ESCs and PiCs correspond to different metastable pluripotent states.
Worth nothing, our data suggest that both generation (ESC PiC transition) and self-renewal of PICs depend on L-Pro oxidation, catalyzed by a mitochondrial enzyme, i.e. POX. In correlation, it has been recently reported that self-renewing divisions of ESCs depend on another amino acid, i.e. threonine, and particularly on its oxidation, catalyzed by a mitochondrial enzyme, i.e. threonine dehydrogenase (Dejosez et al., 2010) . Hence, our data support the intriguing idea that metabolism represent an almost unexplored level of stem cell pluripotency control (Dejosez et al., 2010) . Notably, the almost undetectable level of POX activity in fibroblasts (Semon and Phang, 1991) may explain their inability to proliferate in response to L-Pro. Thus, our data suggest that L-Pro may be used to improve protocols for deriving induced pluripotent stem (iPS) cells from fibroblasts, by selectively promoting ESC/iPS rather than fibroblast proliferation.
Interestingly, the in vitro ESC EpiSC-like transition induced by L-Pro is reminiscent of the in vivo blastocyst epiblast transition occurring during mouse embryo implantation. Consistently, induction of Fgf5, a specific marker of epiblast formation, is essential for efficient ESC PiC transition. Intriguingly, embryo implantation requires extensive degradation of the uterine extra-cellular matrix (ECM) by metalloproteases/ collagenases secreted at the fetal -maternal interface (McEwan et al., 2009) . Since the ECM is mostly (80%) composed of collagen, which is a L-Pro-rich protein (L-Pro and hydroxy-L-Pro together constitute over 25% of collagen amino acids), the level/availability of free L-Pro should increase during embryos implantation. Thus, it is tempting to speculate that L-Pro metabolism may have a role in the complex signaling mechanisms triggering the blastocyst epiblast transition. Our data point to a key role of P5C, the metabolic intermediate of L-Pro ↔ L-Orn interconversion, in the molecular mechanisms underlying morphological transition of ESCs. P5C may be converted into intermediates of Krebs cycle (Figure 3) , which in turn modulate GPCR (G protein-coupled receptor)-dependent signaling (He et al., 2004) . Interestingly, the morphology of the colonies developed by human ESCs and hiPS cells is under the control of GPCR signaling (Nakamura et al., 2009) . In our CPAs, however, a-ketoglutarate, succinate, fumarate, and citric acid all failed to induce PiC formation (our unpublished data), suggesting that P5C exert its morphogenetic activity independently of the Krebs cycle intermediates.
Different reducing agents (GSH, NAC, Vc) are capable of fully antagonizing the morphogenetic (colony phenotype) but not the pro-proliferative activity of L-Pro and L-Orn, suggesting the involvement of different pathways for the induction of proliferation and phenotypic transition. Since GSH, NAC, and Vc are wellknown ROS scavengers, ROS (by-products of L-Pro oxidation via POX, Figure 3 ) could be involved in the control of ESC PiC transition but not cell proliferation. However, POX inhibition failed to counteract L-Orn activity. Moreover, ESC treatment with two different oxidant agents, i.e. doxorubicyn (a mitochondrial superoxide producer) and hydrogen peroxide, failed to induce the ESC PiC transition, even at doses and times sufficient to slow down ESC proliferation (our unpublished data). Finally, oxidants were also unable to enhance the weak morphogenetic activity of L-Orn (our unpublished data). All together, these findings argue against the involvement of ROS in the induction of the ESC PiC transition and suggest that antioxidants, particularly Vc, impair L-Pro activity likely influencing other biological functions. For instance, Vc, which is maintained in its active form (i.e. reduced) by GSH, may influence, acting as a cofactor, the reactions driven by dioxygenases, including collagen prolyl hydroxylases, hypoxia-inducible factor (HIF) prolyl hydroxylases, and histone demethylases (Shi, 2007) . Thus, Vc and P5C and/or L-Pro may induce opposite effects on members of the dioxygenase superfamily, which play a key role in the regulation of reversible ESC ↔ PiC transition. Most remarkably, it has been recently reported that Vc enhances the last step (pre-iPS to iPS cells) of somatic cell reprogramming (Esteban et al., 2010) , which may be correlated to PiC ESC transition.
Materials and methods

Cell culture conditions
Wild-type mouse TBV2 (129/SvP) and R1 ESCs as well as TBV2-derived cells were maintained on a feeder layer of mitomycin C-inactivated primary MEFs; feeder-independent E14 ESCs and PiCs were cultured onto gelatin-coated plates. High glucose DMEM (Gibco, Grand Island, NY, USA) supplemented with 15% ES-screened FBS (HyClone, Logan, UT, USA), 0.1 mM b-mercaptoethanol (Sigma-Aldrich, St Louis, MO, USA), 1 mM sodium pyruvate, 2 mM glutamine, 100 U/ml penicillin/streptomycin, and 1000 U/ml recombinant LIF (Euroclone, Milano, Italy) was used as a culture medium. PiCs were harvested using accutase (Sigma-Aldrich) and cultured in the presence of L-proline (300 -500 mM). bFGF (Invitrogen, Carlsbad, CA, USA) and Activin A (R&D Systems, Inc., Minneapolis, MN, USA) were used at 10 ng/ml and 50 ng/ml, respectively. HEK293, NIH3T3, and MEFS were maintained in high glucose DMEM (Gibco, Grand Island, NY, USA) supplemented with 10% FBS (Euroclone), 1 mM sodium pyruvate, 2 mM glutamine, and 100 U/ml penicillin/streptomycin. For proliferation assays, non-ESCs were plated in ESC-medium with or without L-Pro at 1.5 × 10 4 cells/cm 2 and grown for 36 h. Living cells of triplicate sample were counted with the cell counter Cellometer AUTO T4 (Nexcelom Bioscience, Lawrence, MA, USA) at the time points indicated in the figures.
TBV2-derived cell lines
To generate EGFP-marked ESCs, a reporter vector was constructed by inserting the BamHI/SalI CMV /chicken b-actin promoter into the pEGFP1 plasmid (Clontech, Palo Alto, CA, USA). TBV2 ESCs (2 × 10 7 ) were transfected by using the Nucleofector device (Amaxa Biosystems, Lonza, Cologne) The readout was an Excel worksheet that lists all fluorescence measurements within a specific well on the original plate. A custom Excel worksheet was created to process row measurement data, excluding columns 1 and 12, by mean centering normalization and Z-score transformation. The list output was converted into a matrix containing the Z-score values defined per every well. Hits were selected using a threshold of +3 SD (for Hit selection see also "Statistical analysis"). For CPAs, wild-type TBV2 ESCs were plated at 5 × 10 2 cells/cm 2 and the workflow followed with: (v) 72-h incubation; (vi) medium change/compound addition; (vii) 48-h incubation (viii) PBS wash/PFA fixation/ crystal violet staining (according to Franken et al., 2006) . At day 5, cell colonies were manually counted and classified as typical or atypical colonies using a Leica MZ16 FA fluorescence stereomicroscope.
Manual ESC-based assays When indicated, ESCs were pre-incubated for 1 h with the chemicals/inhibitors (all from Sigma-Aldrich) at the specified concentrations, before addition of L-Pro or L-Orn. For proliferation assays, ESCs, seeded at 1.5-3 × 10 4 cells/cm 2 , were grown for 36-48 h. Triplicate samples were counted by trypan blueexclusion on the Cellometer Auto T4 (Nexcelom Bioscience, Lawrence, MA, USA) at the indicated time points. For CPAs, ESCs or PiCs were seeded at 500 -1000 cells/cm 2 and grown for 4 -5 days, refreshing medium and metabolites/chemicals at day 2 or 3, respectively. For rescue experiments, the recombinant human FGF5 (R&D Systems, Inc.) was added at days 2 and 4. Either living or PFA-fixed cell colonies were counted and classified as domed, flat or domed flat. To calculate the colony formation efficiency, cells were plated at 10 cells/cm 2 in 60 mm dishes; 4 days later, the colonies were counted and referred as percentage over the number of plated cells (240): 98.3% Untreated ESCs (236 + 2), 96.7% L-Pro-treated ESCs (232 + 3), and 97.9% L-Orn-treated ESCs (235 + 2).
In vitro cardiac and neural differentiation For cardiac differentiation, ESCs/PiCs were aggregated as embryoid bodies in high glucose DMEM supplemented with 15% FBS (Euroclone). EBs were prepared by 2-day hanging drop cultures (500 cells/drop) and then grown for 3 days in suspension before allowed to adhere on gelatin-coated tissue culture dishes. Typically, areas of spontaneous contractile cardiomyocytes started appearing after 3 days in culture (day 8) and could be easily identified by Phase contrast microscopy. The serum-free mono-step neural differentiation protocol was previously described (Fico et al., 2008) . Briefly, cells were seeded at 1.5 × 10 3 cells/cm 2 in knockout D-MEM (Gibco) supplemented with 15% knockout serum replacement (Gibco), 0.1 mM b-mercaptoethanol (Sigma-Aldrich), 2 mM glutamine, and 100 U/ml penicillin/streptomycin (Euroclone) and grown for up to 12 days. At the indicated time points, cells were either fixed for immunofluorescence analysis or collected for RNA extraction.
Teratoma formation and blastocyst injection
Seven to eight weeks old Fox Chase SCID mice (Charles River, Chatillon-sur-Chalaronne, France) were used. PiCS and ESCs were detached with accutase (Sigma-Aldrich) or trypsin (Euroclone), respectively, and resuspended in PBS without Na + and Mg 2+ (Euroclone) to a concentration of 1.5 × 10 7 cells/ml. Cells were injected subcutaneously (200 ml, 3 × 10 6 cells/flank) in five animals per group and tumor growth was followed by measuring tumor diameters with a caliper. All the animals injected developed the tumor. When tumors reached on average a volume of 1.5 cm 3 , they were explanted, paraformaldehyde-fixed, and embedded in paraffine following standard procedures. Five micrometer-thick deparaffined tumor sections were stained with hematoxylin-eosin for the analysis. The care and husbandry of mice and xenograft tumor experimental procedures were in accordance with European Directives no. 86/609, and with Italian D.L. 116. All the experiments were approved by the Institute of Genetics and Biophysics veterinarian. For blastocyst injection, PiCs and PiCs rev were generated starting from b-actin/EGFP TBV2 ESCs. Blastocysts were collected from the uterine horns of superovulated CD-1 females mated with CD-1 males. About 40-50 cells (EGFP-marked ESCs, PiCs, and PiCs rev ) per blastocyst were injected, followed by transfer to the uterus of pseudopregnant recipient CD-1 mice. Embryos were dissected at 11.5 days post-coitum (d.p.c.) and EGFP green fluorescence was determined using a Leica MZ16 FA fluorescence stereomicroscope.
Immunofluorescence
Immunofluorescence analysis was performed as described previously (Fico et al., 2008) . Antibodies were the following: rabbit anti-Octamer 3/4 (Abcam; Cambridge, UK), 1:400, 1 h at RT; mouse anti-SSEA1 (Cell Signaling Technology; Beverly, MA, USA), 1:200 O/N 48C; rat anti-E-cadherin (Sigma-Aldrich), 1:100, O/N 48C; mouse anti-bIII-tubulin (Sigma-Aldrich), 1:400, 1 h at RT; rat anti-GFAP (Dako; Glostrup, Denmark), 1:300, 1 h at RT; MF20mouse anti-myosin heavy chain (Developmental Studies Hybridoma Bank; Iowa City, IA, USA), 1:50, 2 h at RT. Appropriate fluorophore-conjugated secondary antibodies were
